Figure 6

Effect of NFAT-133 on plasma glucose and insulin in db/db mice. db/db mice were treated for 10 days, bis in die (b.i.d) with vehicle, NFAT-133 [100 mg/kg, intra-peritoneal (i.p)] or rosiglitazone [5 mg/kg, per os (p.o.)]. Plasma glucose (A) and insulin (B) were measured after 10 days of treatment. All the results are expressed as mean ± standard error of the mean (S.E.M). *** P value < 0.001 vs. vehicle group.